ESRRA and malignant colon neoplasm: Thus, we replaced XCT790 with simvastatin and found that this combination decreased ERRα expression completely and had a synergistic effect, inhibiting proliferation and colony formation in vitro as well as the in vivo tumourigenic capacity of colon cancer cells.